UM Greenebaum Comprehensive Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
UM Greenebaum Comprehensive Cancer Center has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Advanced Non-small Cell Lung Cancer, HER2 Mutation, Metastatic Hormone-sensitive Prostate Cancer.
Sponsors: Bayer.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UM Greenebaum Comprehensive Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UM Greenebaum Comprehensive Cancer Center has 2 clinical trials on record, with 2 currently active. Their work covers Advanced Non-small Cell Lung Cancer, HER2 Mutation, Metastatic Hormone-sensitive Prostate Cancer.
UM Greenebaum Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.